查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829402

2025年全球製氧机市场报告

Artificial Lung Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，氧合器市场规模迅速扩张，从2024年的23.1亿美元成长到2025年的25.8亿美元，复合年增长率为11.6%。预测期内的成长可归因于医疗保健专业人士意识的提升、市场渗透率的提高、居家照护应用的增加、医疗旅游业的蓬勃发展以及医疗基础设施的改善。

预计未来几年人工肺市场规模将快速成长，到2029年将达到39.1亿美元，复合年增长率为11.0%。预测期内的成长可归因于呼吸系统疾病盛行率的上升、医疗设施的改善、微创手术的接受度不断提高、患者生活品质的提高以及慢性阻塞性肺病盛行率的上升。预测期内的主要趋势包括无线技术的整合、人工智慧 (AI) 的整合、基因组学和医疗技术的进步，以及更小巧便携的人工肺的开发。

氧合器是医疗设备，透过给予血液氧气并去除二氧化碳来取代自然肺的功能。它通常用于严重呼吸衰竭的患者，或在手术过程中必须暂时停止心肺功能的患者。该技术旨在支持或取代肺功能，提高患者的存活率和严重患者的康復率。

氧合器的主要类型包括单滚轮泵心肺机、双滚轮泵心肺机、鼓泡式氧合器和膜式氧合器。单一滚轮泵心肺机在心肺体外迴圈手术中使用单一滚轮泵来循环血液。这类机器用于心血管手术、肺移植、急性呼吸衰竭治疗和其他医疗程序，满足各种终端使用者的需求，包括医院、急诊中心和医疗机构。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

氧合器研究报告是商业研究公司最新报告系列的一部分，该系列提供氧合器市场统计数据，包括全球市场规模、区域份额、氧合器市场份额的竞争对手、详细的氧合器市场细分、市场趋势以及氧合器行业的商机。这份氧合器市场研究报告对产业现状和未来趋势进行了详细分析，为您提供所需的一切资讯的完整展望。

预测的五年成长率为11.0%，较我们先前对该市场的预测略有下降0.9%。下降的主要原因是美国与其他国家之间的关税影响。由于德国微孔膜氧合器和瑞典肝素涂层迴路供应中断，导致体外膜氧合器 (ECMO) 和呼吸支持治疗延迟，这一影响将对美国产生直接影响。

由于呼吸系统疾病的日益流行，人工肺市场预计将会成长。这种增长受到空气污染加剧、气候变迁和生活方式改变等因素的影响，给公众健康带来了沉重的负担。人工肺部透过提供氧气、去除血液中的二氧化碳以及支持或替代受损的肺功能，在治疗呼吸系统疾病方面发挥关键作用。例如，根据澳洲健康与福利研究所 2024 年 6 月的报告，估计澳洲约有 850 万人（占总人口的 34%）患有慢性呼吸系统疾病。其中包括 280 万人患有气喘（占总人口的 11%）和 638,000 人慢性阻塞性肺病(COPD)（占总人口的 2.5%）。因此，呼吸系统疾病的日益普及是人工肺部市场扩张的主要驱动力。

氧合器市场涵盖体外膜氧合 (ECMO)、静脉膜氧合 (IVOX)、生物人工肺和微流体氧合器的销售。该市场的价值为“出厂价”，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球氧合器：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球製氧机市场：成长率分析
  • 全球製氧机市场表现：规模与成长，2019-2024
  • 全球製氧机市场预测：规模与成长，2024-2029年，2034年
  • 全球氧合器：总目标市场（TAM）

第六章 市场细分

  • 全球製氧机市场（按产品类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 单滚轮泵心肺机
  • 双滚轮泵心肺机
  • 气泡氧合器
  • 膜式氧合器
  • 全球製氧机市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 心血管手术
  • 肺移植手术
  • 急性呼吸衰竭的治疗
  • 其他用途
  • 全球製氧机市场（依最终用户划分）：2019-2024 年、2024-2029 年、2034 年业绩及预测
  • 医院
  • 急诊中心
  • 其他最终用户
  • 全球氧合器市场：单滚轮帮浦心肺氧合器的细分（按类型）、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 可携式单滚轮泵体外循环机
  • 固定式单滚轮帮浦体外循环机
  • 全球氧合器市场：双滚泵心肺氧合器的细分（按类型）、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 可携式双滚泵体外循环机
  • 固定式双滚轮帮浦体外循环机
  • 全球氧合器市场：按气泡氧合器类型、性能和预测进行细分，2019-2024 年、2024-2029 年、2034 年
  • 一次使用气泡氧合器
  • 可重复使用的气泡氧合器
  • 全球氧合器市场：膜氧合器的细分（按类型）、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 氧合膜氧合器
  • 二氧化碳脱除膜氧合器

第七章 区域和国家分析

  • 全球製氧机市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球製氧机市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 人工肺市场：竞争格局
  • 氧合肺市场：公司简介
    • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Getinge AB Overview, Products and Services, Strategy and Financial Analysis
    • Abiomed Inc. Overview, Products and Services, Strategy and Financial Analysis
    • MicroPort Scientific Corp. Overview, Products and Services, Strategy and Financial Analysis
    • Charles Stark Draper Laboratory Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • TransMedics Group Inc.
  • Braile Biomedica Ltd.
  • Xenios AG
  • MC3 Cardiopulmonary Inc.
  • Lung Biotechnology PBC
  • Breethe Inc.
  • Levitronix LLC
  • Medos Medizintechnik AG
  • ALung Technologies Inc.
  • McGowan Institute for Regenerative Medicine
  • Hemovent GmbH
  • Novalung GmbH
  • Haemair Ltd.
  • MedArray Inc.
  • Vivonics Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年氧合器市场：提供新机会的国家
  • 2029 年氧合器市场：细分市场带来新机会
  • 2029年制氧机市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r29436u

An artificial lung is a medical device created to assume the function of natural lungs by supplying oxygen to the blood and eliminating carbon dioxide. It is commonly employed in patients experiencing severe respiratory failure or during surgeries where temporary cessation of heart and lung function is necessary. This technology aims to support or replace lung function, facilitating patient survival and recovery from critical conditions.

The primary types of artificial lungs include single roller pump heart-lung machines, double roller pump heart-lung machines, bubble artificial lungs, and membrane artificial lungs. A single roller pump heart-lung machine operates using a single roller pump to circulate blood through an artificial lung and back into the patient during cardiopulmonary bypass surgery. These machines are utilized in cardiac surgery, lung transplants, acute respiratory failure treatments, and other medical procedures, catering to diverse end users such as hospitals, emergency centers, and healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The artificial lung research report is one of a series of new reports from The Business Research Company that provides artificial lung market statistics, including the artificial lung industry's global market size, regional shares, competitors with an artificial lung market share, detailed artificial lung market segments, market trends and opportunities, and any further data you may need to thrive in the artificial lung industry. This artificial lung market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial lung market size has grown rapidly in recent years. It will grow from $2.31 billion in 2024 to $2.58 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to growing awareness among healthcare professionals, increasing market penetration, increasing applications in-home care setting, the rise in medical tourism, and improvements in healthcare infrastructure.

The artificial lung market size is expected to see rapid growth in the next few years. It will grow to $3.91 billion in 2029 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to the rising prevalence of respiratory diseases, improvements in healthcare facilities, rising acceptance of minimally invasive procedures, enhanced patient quality of life, and rising prevalence of chronic obstructive pulmonary diseases. Major trends in the forecast period include the integration of wireless technology, artificial intelligence (AI) integration, advances in genomics and medical technology, and the development of smaller, more portable artificial lungs.

The forecast of 11.0% growth over the next five years reflects a modest reduction of 0.9% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply disruptions for microporous oxygenator membranes from Germany and heparin-coated circuits from Sweden, delaying extracorporeal membrane oxygenation (ECMO) and respiratory support treatments.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The artificial lung market is expected to experience growth driven by the increasing prevalence of respiratory diseases. This rise is influenced by factors such as escalating air pollution, climate changes, and shifts in lifestyle, placing a substantial burden on public health. Artificial lungs play a critical role in treating respiratory conditions by providing oxygenation and removing carbon dioxide from the blood, supporting or replacing impaired lung function. For example, as reported by the Australian Institute of Health and Welfare in June 2024, approximately 8.5 million people in Australia, constituting 34% of the population, were estimated to have chronic respiratory conditions. This includes 2.8 million people (11% of the population) with asthma and 638,000 people (2.5% of the population) with chronic obstructive pulmonary disease (COPD). Thus, the growing prevalence of respiratory diseases is a key driver behind the expansion of the artificial lung market.

Major companies in the artificial lung market are focusing on developing innovative solutions, such as remote monitoring and control systems, to gain a competitive edge. These systems enable healthcare professionals to monitor patients' vital signs and adjust ventilation settings remotely, without needing to be physically present at the bedside. This approach helps reduce the risk of infection and improves patient safety during treatment. For example, in August 2022, Teltonika Telemedic, a U.S.-based electronics manufacturer, made significant strides in developing its artificial lung ventilator, TELTOMED. The company secured an exclusive patent for the secure remote transmission and control of its ventilator, enhancing the security and reliability of patient data communication-an essential feature for modern medical devices.

In May 2022, LivaNova plc, a UK-based medical device company, acquired ALung Technologies to bolster its portfolio in advanced respiratory therapies. This acquisition aimed to strengthen LivaNova's capability to deliver innovative solutions for respiratory support, particularly focusing on advancing artificial lung technologies. ALung Technologies, headquartered in the US, specializes in developing intra- and extracorporeal gas exchange devices for treating acute and chronic respiratory disorders.

Major companies operating in the artificial lung market are Terumo Corporation, Getinge AB, Abiomed Inc., MicroPort Scientific Corp., Charles Stark Draper Laboratory Inc., TransMedics Group Inc., Braile Biomedica Ltd., Xenios AG, MC3 Cardiopulmonary Inc., Lung Biotechnology PBC, Breethe Inc., Levitronix LLC, Medos Medizintechnik AG, ALung Technologies Inc., McGowan Institute for Regenerative Medicine, Hemovent GmbH, Novalung GmbH, Haemair Ltd., MedArray Inc., Vivonics Inc., Extracorporeal Life Support (ECLS) Lab

North America was the largest region in the artificial lung market in 2024. The regions covered in the artificial lung market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial lung market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial lung market consists of sales of extracorporeal membrane oxygenation (ECMO), intravenous membrane oxygenators (IVOX), bioartificial lungs, and microfluidic artificial lungs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Lung Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial lung market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial lung ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial lung market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Single Roller Pump Heart Lung Machines; Double Roller Pump Heart Lungs Machines; Bubble Artificial Lung; Membrane Artificial Lung
  • 2) By Application: Cardiac Surgery; Lung Transplant Operation; Acute Respiratory Failure Treatment; Other Applications
  • 3) By End-Users: Hospital; Emergency Center; Other End-users
  • Subsegments:
  • 1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines; Stationary Single Roller Pump Heart Lung Machines
  • 2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines; Stationary Double Roller Pump Heart Lung Machines
  • 3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung; Reusable Bubble Artificial Lung
  • 4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung; Carbon Dioxide Removal Membrane Artificial Lung
  • Companies Mentioned: Terumo Corporation; Getinge AB; Abiomed Inc.; MicroPort Scientific Corp.; Charles Stark Draper Laboratory Inc.; TransMedics Group Inc.; Braile Biomedica Ltd.; Xenios AG; MC3 Cardiopulmonary Inc.; Lung Biotechnology PBC; Breethe Inc.; Levitronix LLC; Medos Medizintechnik AG; ALung Technologies Inc.; McGowan Institute for Regenerative Medicine; Hemovent GmbH; Novalung GmbH; Haemair Ltd.; MedArray Inc.; Vivonics Inc.; Extracorporeal Life Support (ECLS) Lab
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Lung Market Characteristics

3. Artificial Lung Market Trends And Strategies

4. Artificial Lung Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Lung Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Artificial Lung PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Artificial Lung Market Growth Rate Analysis
  • 5.4. Global Artificial Lung Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Artificial Lung Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Artificial Lung Total Addressable Market (TAM)

6. Artificial Lung Market Segmentation

  • 6.1. Global Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Roller Pump Heart Lung Machines
  • Double Roller Pump Heart Lungs Machines
  • Bubble Artificial Lung
  • Membrane Artificial Lung
  • 6.2. Global Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac Surgery
  • Lung Transplant Operation
  • Acute Respiratory Failure Treatment
  • Other Applications
  • 6.3. Global Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Emergency Center
  • Other End-user
  • 6.4. Global Artificial Lung Market, Sub-Segmentation Of Single Roller Pump Heart Lung Machines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Portable Single Roller Pump Heart Lung Machines
  • Stationary Single Roller Pump Heart Lung Machines
  • 6.5. Global Artificial Lung Market, Sub-Segmentation Of Double Roller Pump Heart Lung Machines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Portable Double Roller Pump Heart Lung Machines
  • Stationary Double Roller Pump Heart Lung Machines
  • 6.6. Global Artificial Lung Market, Sub-Segmentation Of Bubble Artificial Lung, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disposable Bubble Artificial Lung
  • Reusable Bubble Artificial Lung
  • 6.7. Global Artificial Lung Market, Sub-Segmentation Of Membrane Artificial Lung, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oxygenator Membrane Artificial Lung
  • Carbon Dioxide Removal Membrane Artificial Lung

7. Artificial Lung Market Regional And Country Analysis

  • 7.1. Global Artificial Lung Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Artificial Lung Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Lung Market

  • 8.1. Asia-Pacific Artificial Lung Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Lung Market

  • 9.1. China Artificial Lung Market Overview
  • 9.2. China Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Lung Market

  • 10.1. India Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Lung Market

  • 11.1. Japan Artificial Lung Market Overview
  • 11.2. Japan Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Lung Market

  • 12.1. Australia Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Lung Market

  • 13.1. Indonesia Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Lung Market

  • 14.1. South Korea Artificial Lung Market Overview
  • 14.2. South Korea Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Lung Market

  • 15.1. Western Europe Artificial Lung Market Overview
  • 15.2. Western Europe Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Lung Market

  • 16.1. UK Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Lung Market

  • 17.1. Germany Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Lung Market

  • 18.1. France Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Lung Market

  • 19.1. Italy Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Lung Market

  • 20.1. Spain Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Lung Market

  • 21.1. Eastern Europe Artificial Lung Market Overview
  • 21.2. Eastern Europe Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Lung Market

  • 22.1. Russia Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Lung Market

  • 23.1. North America Artificial Lung Market Overview
  • 23.2. North America Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Lung Market

  • 24.1. USA Artificial Lung Market Overview
  • 24.2. USA Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Lung Market

  • 25.1. Canada Artificial Lung Market Overview
  • 25.2. Canada Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Lung Market

  • 26.1. South America Artificial Lung Market Overview
  • 26.2. South America Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Lung Market

  • 27.1. Brazil Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Lung Market

  • 28.1. Middle East Artificial Lung Market Overview
  • 28.2. Middle East Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Lung Market

  • 29.1. Africa Artificial Lung Market Overview
  • 29.2. Africa Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Lung Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Lung Market Competitive Landscape
  • 30.2. Artificial Lung Market Company Profiles
    • 30.2.1. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Getinge AB Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abiomed Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. MicroPort Scientific Corp. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Charles Stark Draper Laboratory Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Lung Market Other Major And Innovative Companies

  • 31.1. TransMedics Group Inc.
  • 31.2. Braile Biomedica Ltd.
  • 31.3. Xenios AG
  • 31.4. MC3 Cardiopulmonary Inc.
  • 31.5. Lung Biotechnology PBC
  • 31.6. Breethe Inc.
  • 31.7. Levitronix LLC
  • 31.8. Medos Medizintechnik AG
  • 31.9. ALung Technologies Inc.
  • 31.10. McGowan Institute for Regenerative Medicine
  • 31.11. Hemovent GmbH
  • 31.12. Novalung GmbH
  • 31.13. Haemair Ltd.
  • 31.14. MedArray Inc.
  • 31.15. Vivonics Inc.

32. Global Artificial Lung Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Lung Market

34. Recent Developments In The Artificial Lung Market

35. Artificial Lung Market High Potential Countries, Segments and Strategies

  • 35.1 Artificial Lung Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Artificial Lung Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Artificial Lung Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer